novo nordisk glp 1 drug GLP-1 Fails to Quell Alzheimer's in Trials Ozempic maker Novo Nordisk is

So perhaps meeting recommended nutrient intakes remains achievable

Its not the drug per se, but the cascade of biological changes that come with quick fat loss, caloric restriction, and sometimes nutrient deficiencies

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension

Further, a majority of the sample (82.6%) was White/Caucasian, and 80% of participants reported that GLP-1RA use resulted in greater weight loss than conventional programs

Once your system stabilizes, you can gradually introduce a low-fermentation prebiotic like acacia fiber if you want microbiome support